Remedy Robotics Unveils AI-Powered Remote Endovascular Surgery System

Remedy Robotics has introduced the Remedy N1 System, an AI-powered robotic platform designed for remote endovascular surgery, announced in a press release. The system enables clinicians to perform procedures such as stroke or heart attack interventions from any location, using a combination of proprietary robotics and AI-enabled software.

The company reported that the Remedy N1 System successfully completed the world’s first fully remote in-human neurointerventional procedures. These operations were performed between St. Michael’s Hospital and St. Joseph’s Health Centre in Toronto, demonstrating the ability to conduct endovascular treatments across hospital sites.

The N1 System integrates with standard catheterization labs and allows control of up to four surgical tools simultaneously. It includes AI-assisted imaging integration for CT and MRI scans, providing real-time visibility and precision. Clinicians operate the robot through a portable console capable of managing all instruments, fluidics, and audiovisual communication remotely.

Following these initial procedures, Remedy Robotics plans to expand clinical trials and explore additional cardiovascular applications for its system, which remains under development and is not yet commercially available.